19 results on '"El-Gayed, Ali"'
Search Results
2. Efficacy of adjuvant trastuzumab in women with HER2-positive T1a or bN0M0 breast cancer: a population-based cohort study
3. Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial
4. Outcomes of Rural Men with Breast Cancer: A Multicenter Population Based Retrospective Cohort Study
5. Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6)
6. Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy
7. A compressed sensing based reconstruction algorithm for synchrotron source propagation-based X-ray phase contrast computed tomography
8. Dose–volume analysis of locoregional recurrences in head and neck IMRT, as determined by deformable registration: A prospective multi-institutional trial
9. Efficacy of Fulvestrant in Women with Hormone-Resistant Metastatic Breast Cancer (mBC): A Canadian Province Experience
10. Long-Term Outcome of Breast Cancer Patients with One to Two Nodes Involved – Application of Nodal Ratio
11. Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers
12. Quality of life (QOL) in a phase III randomized trial of standard fractionation radiotherapy (SFX) with concurrent cisplatin (CIS) versus accelerated fractionation radiotherapy (AFX) with panitumumab (PMab) in patients (pts) with locoregionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN): NCIC Clinical Trials Group HN.6 (NCT00820248).
13. Phase II study of hypofractionated image-guided radiotherapy for localized prostate cancer: Outcomes of 55Gy in 16 fractions at 3.4Gy per fraction
14. Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers
15. Human Dendritic Cells Engineered to Express Alpha Tumor Necrosis Factor Maintain Cellular Maturation and T-Cell Stimulation Capacity
16. Combined radiation therapy and dendritic cell vaccine for treating solid tumors with liver micro‐metastasis
17. Time trend of patient setup deviations during pelvic irradiation using electronic portal imaging
18. Combined radiation therapy and dendritic cell vaccine for treating solid tumors with liver micro-metastasis.
19. Phase II study of hypofractionated image-guided radiotherapy for localized prostate cancer: outcomes of 55 Gy in 16 fractions at 3.4 Gy per fraction.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.